Navigation Links
Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
Date:8/2/2009

EAST BRUNSWICK, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) stating that the FDA can not at this time approve the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.

The complete response letter from the FDA cites deficiencies with the chemistry, manufacturing and controls (CMC) section of the BLA and also provided the current draft of the proposed labeling and further guidance regarding a Risk Evaluation and Mitigation Strategy (REMS) (Medication Guide and Communication Plan). The Company intends to immediately request a meeting with the FDA to discuss and clarify the issues raised in the complete response letter. Under FDA regulations, the Company believes that this meeting is deemed a "Type A" meeting, meaning that the FDA would meet with the Company within 30 days of its receipt of the meeting request.

One of the issues raised by the FDA in the complete response letter addresses a change made by the Company in the proposed process for manufacturing KRYSTEXXA for commercial use. The FDA has concluded that the comparability data submitted for the material manufactured using the proposed commercial manufacturing process was not adequate to demonstrate that it was representative of the material used to establish the safety and efficacy of KRYSTEXXA in its Phase 3 clinical trials. The FDA stated that the Company has the option of either reverting to and validating the manufacturing process used to produce KRYSTEXXA for the Phase 3 clinical trials or conducting additional comparability clinical trials to support the use of KRYSTEX
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 03, 2015 Alberto Grignolo, PhD, will ... upcoming Annual Meeting. DIA’s Global Inspire Award program recognizes ... excellence, and commitment to service on a global scale. ... Award that annually recognizes one DIA member for meritorious ... mission of DIA to foster innovation to improve health ...
(Date:6/3/2015)... June 03, 2015 Justina Molzon, MS ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Excellence in Service Award that recognizes the “Member ... a DIA volunteer and who has contributed to the ...
(Date:6/3/2015)... June 03, 2015 Visual BI ... solutions, today announced the launch of the second ... for SAP® BusinessObjects™ Design Studio. The Design Studio ... capabilities and advanced functionalities into their dashboarding projects. ... suite, Visual BI is adding key components for ...
(Date:6/3/2015)... For the fourth time in less than ... full-service advertising agency, has been honored by a respected independent ... MCA has been selected as a Semi-Finalist for the 2015 ... honored at a luncheon sponsored by Adcock Financial Group and ... Art. , “This luncheon will include important information about the ...
(Date:6/3/2015)... June 03, 2015 On Sunday, June ... world will gather in their local communities to observe ... cities across the U.S. and abroad will hold celebrations ... attention to the ongoing challenges of cancer survivorship, and ... diagnosis can be fruitful, rewarding, and inspiring.,  , National ...
Breaking Medicine News(10 mins):Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4
... 26 The AMERIGROUP Foundation,today announced that Senator ... its "Champion for Children" award., The award ... outstanding public advocacy efforts by government and community,leaders ... "Our goal is to work together with ...
... a company,developing breakthrough molecular imaging agents for ... it has entered into a licensing,agreement with ... and,commercialization of agents for diagnosis and treatment ... were co-developed by,FluoroPharma and MGH scientists, target ...
... plagues African populations , , WEDNESDAY, March 26 (HealthDay News) ... from the environment the organism that causes devastating and ... according to a new report. , The study ... idea that the organism, Mycobacterium ulcerans , is ...
... Partnership Develops First-Ever Toolkits to Address ,The ... in America Today, SACRAMENTO, Calif., March 26 ... activities, the California Association of,Health Plans (CAHP) and ... up to encourage physicians to discuss healthier,lifestyles with ...
... by the National Oncologic PET Registry (NOPR) showing that ... a molecular level, which then caused physicians to change ... has corroborated decades of nuclear medicine research. , These ... some time: molecular imaging is a powerful tool in ...
... Corporation will host,their second annual medical device ... in Bedford, Massachusetts., (Logo: http://www.newscom.com/cgi-bin/prnh/20071228/TOXIKONLOGO ... to be updated and revised,medical device manufacturers ... product. With new innovations and applications in,development, ...
Cached Medicine News:Health News:Texas Senator Kirk Watson Honored as 'Champion for Children' by the AMERIGROUP Foundation 2Health News:FluoroPharma Inc. Expands Technology Platform to Include Agents for Alzheimer's Disease (AD) 2Health News:Scientists Isolate Organism That Causes Disfiguring Tropical Disease 2Health News:California Association of Health Plans & California Medical Association Foundation Team Up to Combat Obesity 2Health News:California Association of Health Plans & California Medical Association Foundation Team Up to Combat Obesity 3Health News:California Association of Health Plans & California Medical Association Foundation Team Up to Combat Obesity 4Health News:PET confirmed as valuable cancer diagnostic and disease-staging tool 2
(Date:6/3/2015)... AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ... today that their customer, Pharmabox, has introduced the world,s ... carries over 140 top selling brand name items typically ... Rite Aid-type store. As published in ... Miami -based Pharmabox worked with AVT to develop ...
(Date:6/3/2015)... , June 3, 2015  Flow cytometry ... around the globe and keeping track of wide-ranging ... competitive market. In particular, ensuring user-friendliness, fluorescence capabilities, ... are the most important factors influencing end-user purchase ... base. New analysis from Frost & ...
(Date:6/3/2015)... June 3, 2015 Varian Medical Systems (NYSE: ... selected to equip and service the new multi-room HollandPTC ... The company will book the equipment part of the ... HollandPTC is a key part of Medical Delta, the ... of Leiden, Delft and Rotterdam . ...
Breaking Medicine Technology:Pharmabox Introduces New Concept with a Boldly Designed Automated Retailing System 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 2Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 3Florescent Capabilities are the Primary Focus for Laboratories with Flow Cytometer Technologies 4Varian Medical Systems to Equip Proton Therapy Center in Netherlands 2Varian Medical Systems to Equip Proton Therapy Center in Netherlands 3
... Diagnostics Incorporated (NYSE: DGX ), the world,s leading ... Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended ... shares of common stock of Celera Corporation (NASDAQ: ... p.m., New York City time, today, May 3, 2011, unless ...
... Calif., May 3, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... that it has entered into a definitive agreement with ... Life Sciences, to raise approximately $16.1 million in gross ... of common stock and warrants.  The Company agreed to ...
Cached Medicine Technology:Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today 2Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today 3Alexza Prices $16.1 Million Registered Direct Offering 2Alexza Prices $16.1 Million Registered Direct Offering 3Alexza Prices $16.1 Million Registered Direct Offering 4
Straight shaft with fine pointed 0.3mm Tips for Grasping Delicate Capsule; In Titanium....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
Gently curved 5mm Platform With 12, 0.12mm Teeth; In Titanium....
Medicine Products: